Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.009x

Based on the latest financial reports, Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has a cash flow conversion efficiency ratio of -0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-15.07 Million ≈ $-2.21 Million USD) by net assets (CN¥1.74 Billion ≈ $254.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Jiangsu Lianhuan Pharmaceutical Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.

Jiangsu Lianhuan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Jiangsu Lianhuan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jiangsu Lianhuan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Lianhuan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Bintulu Port Holdings Bhd
KLSE:5032
0.060x
Raydium Semi-Conductor
TW:3592
-0.003x
COMPASS PATHW SP.ADR
F:5Y6
0.715x
Zhongyin Babi Food Co. Ltd.
SHG:605338
0.102x
Biotest Aktiengesellschaft
XETRA:BIO3
-0.114x
Nanjing Bestway Intelligent Control Technology Co. Ltd. A
SHE:301195
N/A
Chapters Group AG
XETRA:CHG
0.040x
Hunan Sokan New Materials Co. Ltd. A
SHG:688157
N/A

Annual Cash Flow Conversion Efficiency for Jiangsu Lianhuan Pharmaceutical Co Ltd (2002–2024)

The table below shows the annual cash flow conversion efficiency of Jiangsu Lianhuan Pharmaceutical Co Ltd from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Jiangsu Lianhuan Pharmaceutical Co Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥1.58 Billion
≈ $230.80 Million
CN¥10.77 Million
≈ $1.58 Million
0.007x -93.56%
2023-12-31 CN¥1.52 Billion
≈ $222.03 Million
CN¥160.70 Million
≈ $23.52 Million
0.106x +17.35%
2022-12-31 CN¥1.41 Billion
≈ $206.87 Million
CN¥127.59 Million
≈ $18.67 Million
0.090x -16.44%
2021-12-31 CN¥1.28 Billion
≈ $187.44 Million
CN¥138.34 Million
≈ $20.24 Million
0.108x +38.86%
2020-12-31 CN¥1.18 Billion
≈ $172.97 Million
CN¥91.94 Million
≈ $13.45 Million
0.078x +954.26%
2019-12-31 CN¥1.08 Billion
≈ $158.63 Million
CN¥-9.87 Million
≈ $-1.44 Million
-0.009x +90.63%
2018-12-31 CN¥946.61 Million
≈ $138.52 Million
CN¥-92.00 Million
≈ $-13.46 Million
-0.097x -2447.48%
2017-12-31 CN¥878.23 Million
≈ $128.51 Million
CN¥3.64 Million
≈ $532.06K
0.004x -95.13%
2016-12-31 CN¥827.25 Million
≈ $121.05 Million
CN¥70.28 Million
≈ $10.28 Million
0.085x +5.99%
2015-12-31 CN¥774.88 Million
≈ $113.39 Million
CN¥62.12 Million
≈ $9.09 Million
0.080x -49.91%
2014-12-31 CN¥434.25 Million
≈ $63.54 Million
CN¥69.50 Million
≈ $10.17 Million
0.160x +73.13%
2013-12-31 CN¥402.11 Million
≈ $58.84 Million
CN¥37.17 Million
≈ $5.44 Million
0.092x +91.22%
2012-12-31 CN¥350.42 Million
≈ $51.28 Million
CN¥16.94 Million
≈ $2.48 Million
0.048x -34.00%
2011-12-31 CN¥327.61 Million
≈ $47.94 Million
CN¥24.00 Million
≈ $3.51 Million
0.073x +168.56%
2010-12-31 CN¥308.95 Million
≈ $45.21 Million
CN¥8.43 Million
≈ $1.23 Million
0.027x -42.05%
2009-12-31 CN¥293.89 Million
≈ $43.01 Million
CN¥13.83 Million
≈ $2.02 Million
0.047x -23.99%
2008-12-31 CN¥281.68 Million
≈ $41.22 Million
CN¥17.44 Million
≈ $2.55 Million
0.062x +108.09%
2007-12-31 CN¥269.97 Million
≈ $39.51 Million
CN¥8.03 Million
≈ $1.18 Million
0.030x -23.97%
2006-12-31 CN¥259.20 Million
≈ $37.93 Million
CN¥10.14 Million
≈ $1.48 Million
0.039x +162.08%
2005-12-31 CN¥255.97 Million
≈ $37.46 Million
CN¥3.82 Million
≈ $559.35K
0.015x +10.21%
2004-12-31 CN¥250.42 Million
≈ $36.64 Million
CN¥3.39 Million
≈ $496.50K
0.014x +125.29%
2003-12-31 CN¥246.22 Million
≈ $36.03 Million
CN¥-13.19 Million
≈ $-1.93 Million
-0.054x -123.77%
2002-12-31 CN¥85.26 Million
≈ $12.48 Million
CN¥19.22 Million
≈ $2.81 Million
0.225x --

About Jiangsu Lianhuan Pharmaceutical Co Ltd

SHG:600513 China Drug Manufacturers - Specialty & Generic
Market Cap
$657.06 Million
CN¥4.49 Billion CNY
Market Cap Rank
#11024 Global
#3109 in China
Share Price
CN¥15.73
Change (1 day)
-0.76%
52-Week Range
CN¥9.27 - CN¥30.75
All Time High
CN¥30.75
About

Jiangsu Lianhuan Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals, preparations, and active pharmaceutical ingredients (API) products in China and internationally. The company offers clopidogrel bisulfate tablets, doxycycline hydrochloride, azithromycin, milrinone, dapoxetine hydrochloride, tadalafil, and betasine besylate tablets, as well as aprili… Read more